VRCA - Verrica Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRCA is currently covered by 5 analysts with an average price target of $14.46. This is a potential upside of $7.2 (99.17%) from yesterday's end of day stock price of $7.26.

Verrica Pharmaceuticals's activity chart (see below) currently has 34 price targets and 39 ratings on display. The stock rating distribution of VRCA is 15.79% HOLD and 84.21% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 8.21% with an average time for these price targets to be met of 58.71 days.

Highest price target for VRCA is $14, Lowest price target is $8, average price target is $14.46.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 01-Mar-2024. First documented stock forecast 21-Feb-2019.

Currently out of the existing stock ratings of VRCA, 3 are a HOLD (15.79%), 16 are a BUY (84.21%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8

$0.74 (10.19%)

8

2 months 5 days ago

1/8 (12.5%)

$2.45 (44.14%)

253

Buy

13

$5.74 (79.06%)

12

2 months 5 days ago

0/12 (0%)

$7.45 (134.23%)

Buy

10

$2.74 (37.74%)

10

4 months 21 days ago

0/2 (0%)

$3.91 (64.20%)

Buy

14

$6.74 (92.84%)

4

9 months 11 days ago

1/4 (25%)

$8.68 (163.16%)

79

Buy

14

$6.74 (92.84%)

11

9 months 11 days ago

1/5 (20%)

$8.68 (163.16%)

79

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRCA (Verrica Pharmaceuticals) average time for price targets to be met?

On average it took 58.71 days on average for the stock forecasts to be realized with a an average price target met ratio 8.21

Which analyst has the current highest performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?

SERGE BELANGER

Which analyst has the current lower performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?

GLEN SANTANGELO

Which analyst has the most public recommendations on VRCA (Verrica Pharmaceuticals)?

Serge Belanger works at NEEDHAM and has 4 price targets and 7 ratings on VRCA

Which analyst is the currently most bullish on VRCA (Verrica Pharmaceuticals)?

Kemp Dolliver with highest potential upside - $16.47

Which analyst is the currently most reserved on VRCA (Verrica Pharmaceuticals)?

Serge Belanger with lowest potential downside - $0.74

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?